Understanding 5CLADBA: An Overview For Responsible Research - Revision history

BillyTrego at 19:03, 28 May 2026

2026-05-28T19:03:29Z

ISZCindy643869 at 03:42, 27 May 2026

2026-05-27T03:42:52Z

BillyTrego at 03:39, 27 May 2026

2026-05-27T03:39:10Z

BillyTrego at 03:30, 27 May 2026

2026-05-27T03:30:59Z

ErvinWalters273 at 07:07, 26 May 2026

2026-05-26T07:07:44Z

WarnerMoroney53: Created page with "A 30-min period, beginning when maximal depression of locomotor activity first appeared as a function of dose, was used for analysis of dose-response data and calculation of E..."

2026-05-25T07:19:08Z

Created page with "A 30-min period, beginning when maximal depression of locomotor activity first appeared as a function of dose, was used for analysis of dose-response data and calculation of E..."

New page

A 30-min period, beginning when maximal depression of locomotor activity first appeared as a function of dose, was used for analysis of dose-response data and calculation of ED50 values. During test sessions, both levers were active, such that ten consecutive responses on either lever led to i thought about this reinforcement. The substitution tests occurred only if the rats had achieved 85% injection-appropriate responding on the two prior training sessions. The locomotor activity assay was used to identify approximate time courses and dose ranges of psychoactive effects, which is useful for identifying parameters for drug discrimination experiments and are also predictive of the time course of the psychoactive effects in human users. The purpose of the present study was to assess the abuse liability of 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA. Since there is currently no robust measure of the reinforcing/rewarding effects of cannabinoids, drug discrimination is currently the best model for assessing abuse liability of cannabinoids. The findings produce an apparent paradox, since CPP and self-administration predict with high reliability the likelihood that a compound will be abused by humans, and cannabinoids are well-known to produce active drug-seeking in human In summary, JWH-210 Chemical Powder stands out as a high-quality research compound designed for professionals who demand accuracy, consistency, and reliability. This commitment to [https://cannabinoidsrc4f-adb.com/ i thought about this] quality makes it a trusted option for professionals who require dependable compounds for their work. From sourcing raw materials to final packaging, every stage of the process is monitored to ensure compliance with laboratory-grade expectations. This makes it an ideal choice for laboratories that prioritize both efficiency and compliance with research standards. Key Features and Specifications to Evaluate In case of cannabis or Δ9-tetrahydrocannabinol, there are many i thought about this previous studies regarding with their dependence potential and neurotoxicity (Cororan, et al., 1974; Harris, et al., 1974; Leite and Culini, 1974; Hutcheson, et al., 1998). After administering test substances once every other day for 10 days, brain samples of mice were collected, especially at nucleus accumbens and hippocampus regions. Drug was administered 5 times every other day, and the first trial was performed 2 h after the last administration. How to Choose Powder JWH-210 When learning how to choose powder JWH-210, the most critical factor is verifying high chemical purity (≥98%) from a reputable supplier with independent lab testing. We also demonstrated that JWH-210 administration resulted in the decrease of expression levels of T-cell activator including Cd3e, Cd3g, Cd74p31, and Cd74p41, while JWH-030 increased Cd3g levels. JWH-210 (10 mg/kg, 3 days, i.p.) is more likely to have cytotoxicity and reduce lymphoid organ weight than JWH-030 of ICR mice in vivo. Users are expected to handle the compound in accordance with all applicable regulations and safety guidelines within their jurisdiction. It is important to note that JWH-210 Chemical Powder is intended strictly for research and laboratory use only. Its reputation for purity and stability has contributed to its widespread use in controlled environments where precision is paramoun AMB-FUBINACA has been implicated in severe adverse effects in recreational users (Adams et al., 2017; Hamilton et al., 2017), which suggests that the range between behaviorally active and toxic doses of AMB-FUBINACA is narro Moreover, a study conducted in the United Kingdom investigated components of e-liquids in 112 samples originating from prisoners, teenagers and test purchases of commercially available e-cigarettes taken between 2014 and 2021 . This is the first case report that describes the toxicological symptoms of vaping ADB-BUTINACA. Results of the DOA test (including testing for amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, methadone, opioids, cannabis, tricyclic antidepressants) were available within 30 minutes and were all negative. We report a case of an involuntary intoxication of the SCRA ADB-BUTINACA after vaping. There are several pitfalls in the detection of SCRA in samples taken from the patien The findings produce an apparent paradox, since CPP and self-administration predict with high reliability the likelihood that a compound will be abused by humans, and cannabinoids are well-known to produce active drug-seeking in human A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporise. A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours

← Older revision		Revision as of 19:03, 28 May 2026
Line 1:		Line 1:
−	§ (~~3) of the Hungarian act of Forensic Experts (2016.XXIX~~), ~~the data of the reported case can be utilized freely for scientific and educational purposes without special ethical permission. These results indicate~~ that ~~the simultaneous~~ intoxication of SCRA ~~and ethanol directly and exclusively caused the death of the two victims. The victims did~~ not ~~have any significant diseases that could have contributed to the outcome. Very limited data are~~ available ~~in the scientific literature about the possible effects of the combined consumption of SCRAs and ethanol~~. ~~Several case reports describe~~ that the ~~presence~~ of ~~a little ng~~/~~mL (~~0~~.37–4.1~~) ~~of SCRAs~~ and ~~a high—but not lethal—concentration of ethanol~~ (1~~.45–2.~~7 ~~g/L~~) ~~directly~~ and ~~exclusively contributed to the death of the victim [24–27] (Table 2)~~. ~~The fact that 4F~~-~~MDMB-BINACA~~ was ~~not~~ detected in ~~postmortem urine samples is partly explained by the high rate~~ of ~~hepatic metabolism of SCRAs [11~~, 14, ~~22], but also suggests that the victims consumed 4F-MDMB-BINACA shortly before their death~~<br><br><br>These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-~~MDMB~~-~~PINACA (also known as 5F-ADB~~, 5F-~~ADB-PINACA)~~, ~~MDMB~~-~~CHIMICA, MDMB-FUBINACA, ADB-FUBINACA,~~ and ~~AMB~~-~~FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit~~<br>~~<br><br>Inclusion~~ in ~~an NLM database does not imply endorsement of, or agreement with,~~ the ~~contents~~ by ~~NLM or the National Institutes~~ of ~~Health. It is illegal to sell~~, ~~distribute, supply, transport or trade the pharmaceutical~~ drug ~~under~~ the ~~Psychoactive Substances Act 2016. The corresponding indole core analogue,~~ 4F-MDMB-~~BICA~~ (~~4F-MDMB-BUTICA~~), ~~has also been widely sold as a designer drug by chemical providers on~~ the ~~internet, first being identified~~ in ~~May 2020~~. ~~It has been used as an active ingredient~~ in ~~synthetic cannabis products and sold as a designer drug since late 2018. 4F~~-~~MDMB~~-~~BINACA (also known~~ as MDMB-~~4F-BINACA using systematic EMCDDA nomenclature or 4F-~~MDMB-~~BUTINACA) is an indazole~~-~~based synthetic cannabinoid from the indazole-3-carboxamide family.<br>Fig. <br><br><br>In summary~~, ~~JWH-210 Chemical Powder stands out as a high-quality research compound designed for professionals who demand accuracy, consistency, and reliability~~. ~~This commitment~~ to ~~[https://cannabinoidsrc4f~~-~~adb.com/ adb butinaca] quality makes it a trusted option for professionals who require dependable compounds for their work. From sourcing raw materials to final packaging~~, ~~every stage of the process is monitored to ensure compliance with laboratory~~-grade expectations. This makes it an ideal choice for laboratories that prioritize both efficiency and compliance with research standards.<br>Key Features and Specifications to Evaluate <br>In case of cannabis or Δ9-~~tetrahydrocannabinol, there are many adb butinaca previous studies regarding with their dependence potential and neurotoxicity~~ (~~Cororan, et al., 1974; Harris, et al., 1974; Leite and Culini, 1974; Hutcheson, et al., 1998~~)~~. After administering test substances once every other day~~ for ~~10 days, brain samples of mice were collected, especially at nucleus accumbens~~ and ~~hippocampus regions. Drug was administered 5 times every other day~~, ~~and~~ the ~~first trial was performed 2 h after the last administration.<br>How to Choose Powder JWH-210 <br>This dual-use nature underscores the importance~~ of responsible sourcing and strict adherence to legal frameworks. Forensic labs, public health researchers, and customs officials use authentic samples like JWH-210 to distinguish between legal and illegal compounds in seized materials. For those seeking a dependable compound for analytical purposes, JWH-210 Chemical Powder provides a trusted and effective solution. With its carefully controlled production process, stable composition, and secure packaging, it remains a valuable resource for laboratory-based research.<br>~~Is JWH-210 Legal?~~ <br>~~A total of 2 and 3 methamphetamine treated mice fell from the spinning rod 30 min and 2 hr after the administration, respectively. After the first injection, 6 mice of the positive~~ control ~~group (methamphetamine~~, ~~5 mg/kg, i.p.) showed loss of traction, of which 4 showed tremor. Most of~~ the ~~abnormalities were normalized in synthetic cannabinoid treated mice although those abnormal behaviors remained in methamphetamine treated animals after 2 hr of administration. Brain samples~~ were ~~prepared~~ from the ~~mice after~~ the ~~last administration~~ of test ~~substance~~<br><br><br>A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporise. A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours	+	As synthetic cannabinoid receptor agonists (SCRA) are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests. He confirmed that he had been vaping an electronic cigarette (e-cigarette) earlier that day just before the onset of his symptoms. Metabolic acidosis (1/3, 0/7) and respiratory acidosis (1/3, 0/7), All 10 patients recovered with supportive care, including intubation and ventilation for one case. In 3 cases ADB-BUTINACA was the only substance detected, while in seven other substances of misuse were also detected including other SCRA, opioids, benzodiazepines cocaine and pregabali<br><br>Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans <br>The % peak area abundance ratio of metabolites detected in the urine samples are often affected by numerous factors such as drug intake behaviour (intake route, amount of drug and intake frequency), time from last drug intake and metabolic stability. This indicated that the phase I metabolism of 4F-MDMB-BINACA are unlikely to be affected significantly by polydrug intake. Oxidative defluorination with subsequent butanoic acid formation (B17) metabolite, the second major metabolite after monohydroxylation in the C. Ester hydrolysis with dehydrogenation formed in-vivo in this study was also reported among other indazole carboxamide type SCBs with tert-leucine methyl ester moieties such as 5F-MDMB-PINACA and MDMB-4en-PINACA [39, 40]. Similar to the in-vivo findings, 4F-MDMB-BINACA ester hydrolysis (B22) was the major metabolite for both HepG2 and HLM models, consistent with the known hydrolytic activity of CES reported<br><br>Because response suppression may compromise stimulus control, rats failing to complete at least ten responses during the test session were excluded from the analysis of the discriminative stimulus effects of that dose of test compoun<br><br><br>A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporise. A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours<br><br><br>Some mice showed abnormal behaviors (catalepsy, loss of traction, convulsion) right after the administration of the tested substances. The locomotor activity of the mice was measured 30 min and 2 hrs after the last substance administration. We also examined their neurotoxicity using brain samples through histopathological diagnose, especially in the nucleus accumbens core region. In histopathological analysis, neural cells of the animals treated with the high dose (5 mg/kg) of JWH-081 or JWH-210 showed distorted nuclei and nucleus membranes in the core shell of nucleus accumbens, suggesting neurotoxicity.<br>Table of Conten<br><br><br>High resolution mass spectrometry such as LC-QTOF-MS allows the detection and identification of a broad spectrum of recreational drugs, including new psychoactive substances. A point-of-care drugs of abuse (DOA) test was initially performed on the urine of the patient. He confirmed drinking 750 ml energy drink without any further consumption of food and using an e-cigarette from Gaziantep, Turkey 10 seconds before the onset of his first symptoms. He usually smokes a pack of cigarettes a day and sometimes smokes e-cigarettes. Combined with non-specific, transient symptoms, clinical recognition of SCRA intoxication is challenging .<br>Data availability <br>The intensity is plotted against the retention time for both chromatograms, demonstrating the cannabinoidsrc4f-adb.com`s [https://cannabinoidsrc4f-adb.com/ cannabinoidsrc4f-adb.com`s statement on its official blog] on its official blog presence and elution profiles of nicotine and ADB-BUTINACA in the analysed vape liquid sample. LC-QTOF-MS Chromatograms of Nicotine (Top) and ADB-BUTINACA (Bottom) in the Vape Liquid used by the patient. The LC-QTOF-MS analysis showed that the e-liquid contained nicotine and ADB-BUTINACA (Fig. 1). Because the point-of-care DOA test is generally not able to detect synthetic recreational drug substances, the liquid of the e-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER, the nausea complaints of the patient were reduced and the patient was discharged hom<br><br><br>Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. Average potency of the discriminative stimulus effects of early compounds was 0.81±0.17 mg/kg (Gatch et al., 2014), whereas the potency of a recent set was 0.09±0.03 mg/kg (Gatch et al., 2018), and the potency of the current set is 0.05±0.01 mg/kg. Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound

← Older revision		Revision as of 03:42, 27 May 2026
Line 1:		Line 1:
−	These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br><br>~~The current study indicates that~~ the ~~test compounds produce locomotor depression similar~~ to ~~that of Δ9-THC~~, ~~and fully substitute for~~ the ~~discriminative stimulus effects of Δ9-THC~~. ~~In summary~~, ~~these 5F~~-MDMB-~~PINACA, MDMB~~-~~CHIMICA,~~ MDMB-~~FUBINACA~~, ~~ADB-FUBINACA, and AMB-FUBINACA have similar abuse liability~~ as ~~Δ9-tetrahydrocannabinol and should be controlled in~~ a ~~similar fashion. Much of~~ the in ~~vivo cannabinoidsrc4f-adb~~.~~com testing of the synthetic cannabinoid compounds have~~ been ~~pre-clinical studies focused on their cannabinoid-like effects or like the present study, focused on their abuse liability. There is indication that at least some of the first-generation~~ synthetic ~~cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016),~~ and a ~~compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al~~.~~, 2016<br><br>5F~~-MDMB-~~PINACA~~ (also known as 5F-~~ADB, 5F~~-~~ADB~~-~~PINACA),~~ MDMB-~~CHIMICA, MDMB~~-~~FUBINACA, ADB~~-~~FUBINACA, and AMB~~-~~FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit~~<br><br>~~4. Drugs~~ <br>In ~~general~~, ~~the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received~~ JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a ~~one~~-~~way analysis of variance was conducted on horizontal activity counts~~ for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval. Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor.<br>Michael B Gatch <br>Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and ~~maximal depression was observed between 10–40 min and lasted up to 2~~.5 to ~~3 h at the~~ [https://cannabinoidsrc4f-adb.com/ ~~cannabinoidsrc4f-~~adb.~~com] highest dose tested (0~~.~~5 mg/kg)~~.<br>~~Figure 1.~~ <br>~~There is indication that at least some~~ of ~~the first~~-~~generation synthetic cannabinoids act at receptors other than cannabinoid CB1~~ and ~~CB2~~ (~~Wiley~~ et al., ~~2016)~~, and ~~a compound from the present study~~, ~~5F-MDMB-PINACA, was found to activate midbrain dopamine neurons~~, ~~but not serotonin neurons (Asaoka~~ et al., ~~2016~~). ~~As previously mentioned~~, ~~all~~ of the ~~compounds tested in~~ the ~~present study (MDMB~~-~~PINACA~~, ~~MDMB-CHMICA~~, ~~MDMB~~-~~FUBINACA~~, ~~ADB~~-~~FUBINACA,~~ and ~~AMB-FUBINACA) act as agonists at CB1 receptors (Banister et al~~., ~~2015~~, ~~2016; Gamage et al.~~, ~~2018), which suggests these compounds will produce Δ9~~-~~THC~~-~~like effects~~, ~~including abuse liability~~. ~~Tremors were not observed following AMB-FUBINACA during~~ the ~~drug discrimination study~~, ~~but~~ the ~~maximum dose tested was only 0.1~~ mg/kg, which ~~is 10-fold lower than~~ the ~~dose that produced tremors~~ in the mice.<br>~~Michael B Gat~~<br><br>~~<br>Similarly~~, ~~precursor ion identified at m/z 380 (B19/B21~~, ~~B23/B25) was 16 Da higher than the 4F-MDMB-BINACA~~, ~~indicating monohydroxylation at the butyl side chain (B19/B21)~~ and ~~indazole (B23/B25) moieties with product ions m/z 145 and 161~~, ~~respectively. Metabolites identified at m/z 366 (B8~~, B9, ~~B13~~), ~~which was 16 Da higher than the 4F~~-~~MDMB-BINACA ester hydrolysis metabolite~~ (~~B22~~)~~, confirmed monohydroxylation upon ester hydrolysis. Death involving these drugs have been reported [5,6,7,8,9],~~ and ~~this raises public health and social concerns. Due to their similar physiological effects~~ to the ~~principal psychoactive component~~ of ~~cannabis, Δ9~~-~~tetrahydrocannabinol (THC)~~, ~~SCBs are gaining popularity and are often abused as recreational drugs~~. ~~The fact~~ that ~~similar 4F-MDMB-BINACA and ethanol concentrations were detected in~~ the ~~postmortem blood samples of both victims suggests that both substances played a role in~~ the ~~fatal outcom~~	+	§ (3) of the Hungarian act of Forensic Experts (2016.XXIX), the data of the reported case can be utilized freely for scientific and educational purposes without special ethical permission. These results indicate that the simultaneous intoxication of SCRA and ethanol directly and exclusively caused the death of the two victims. The victims did not have any significant diseases that could have contributed to the outcome. Very limited data are available in the scientific literature about the possible effects of the combined consumption of SCRAs and ethanol. Several case reports describe that the presence of a little ng/mL (0.37–4.1) of SCRAs and a high—but not lethal—concentration of ethanol (1.45–2.7 g/L) directly and exclusively contributed to the death of the victim [24–27] (Table 2). The fact that 4F-MDMB-BINACA was not detected in postmortem urine samples is partly explained by the high rate of hepatic metabolism of SCRAs [11, 14, 22], but also suggests that the victims consumed 4F-MDMB-BINACA shortly before their death<br><br><br>These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br><br>Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. It is illegal to sell, distribute, supply, transport or trade the pharmaceutical drug under the Psychoactive Substances Act 2016. The corresponding indole core analogue, 4F-MDMB-BICA (4F-MDMB-BUTICA), has also been widely sold as a designer drug by chemical providers on the internet, first being identified in May 2020. It has been used as an active ingredient in synthetic cannabis products and sold as a designer drug since late 2018. 4F-MDMB-BINACA (also known as MDMB-4F-BINACA using systematic EMCDDA nomenclature or 4F-MDMB-BUTINACA) is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family.<br>Fig. <br><br><br>In summary, JWH-210 Chemical Powder stands out as a high-quality research compound designed for professionals who demand accuracy, consistency, and reliability. This commitment to [https://cannabinoidsrc4f-adb.com/ adb butinaca] quality makes it a trusted option for professionals who require dependable compounds for their work. From sourcing raw materials to final packaging, every stage of the process is monitored to ensure compliance with laboratory-grade expectations. This makes it an ideal choice for laboratories that prioritize both efficiency and compliance with research standards.<br>Key Features and Specifications to Evaluate <br>In case of cannabis or Δ9-tetrahydrocannabinol, there are many adb butinaca previous studies regarding with their dependence potential and neurotoxicity (Cororan, et al., 1974; Harris, et al., 1974; Leite and Culini, 1974; Hutcheson, et al., 1998). After administering test substances once every other day for 10 days, brain samples of mice were collected, especially at nucleus accumbens and hippocampus regions. Drug was administered 5 times every other day, and the first trial was performed 2 h after the last administration.<br>How to Choose Powder JWH-210 <br>This dual-use nature underscores the importance of responsible sourcing and strict adherence to legal frameworks. Forensic labs, public health researchers, and customs officials use authentic samples like JWH-210 to distinguish between legal and illegal compounds in seized materials. For those seeking a dependable compound for analytical purposes, JWH-210 Chemical Powder provides a trusted and effective solution. With its carefully controlled production process, stable composition, and secure packaging, it remains a valuable resource for laboratory-based research.<br>Is JWH-210 Legal? <br>A total of 2 and 3 methamphetamine treated mice fell from the spinning rod 30 min and 2 hr after the administration, respectively. After the first injection, 6 mice of the positive control group (methamphetamine, 5 mg/kg, i.p.) showed loss of traction, of which 4 showed tremor. Most of the abnormalities were normalized in synthetic cannabinoid treated mice although those abnormal behaviors remained in methamphetamine treated animals after 2 hr of administration. Brain samples were prepared from the mice after the last administration of test substance<br><br><br>A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporise. A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours

← Older revision		Revision as of 03:39, 27 May 2026
Line 1:		Line 1:
−	~~All of the compounds tested in the present study depressed locomotor activity as is typical for other~~ synthetic cannabinoids (~~see review by Wiley~~ et al., ~~2017~~). ~~Average horizontal activity counts~~/10 min as ~~a function of time~~ (~~10 min bins~~) ~~and dose. Depressant effects of 1.33 mg/kg~~ were ~~observed within 10 min following administration and peak depressant~~ effects ~~were Click Link observed between 0–30 min. Duration of the locomotor depression increased over dose from 30 min following 0.1 mg/kg~~ to ~~2.5 h following 1 mg/k~~<br><br><br>~~This makes JWH-210 powder one of~~ the ~~most powerful~~ compounds ~~in its class~~, ~~often used in incense blends~~ and ~~research settings. Our commitment to quality and customer satisfaction makes us~~ the ~~best place for jwh 210 buy~~-~~whether you need it for research, incense blends, or other legal applications~~. ~~For qualified professionals~~, ~~investing in high~~-~~quality~~, ~~verified material ensures accuracy~~, ~~safety~~, ~~and regulatory compliance. Prioritize vendors providing full analytical validation, transparent documentation~~, and ~~compliance with international controls. Value is best assessed through consistency, verifiable purity,~~ and regulatory compliance—not cost alon<br><br><br>Observation item 1st injection 2nd injection 3rd injection 4th injection 5th injection Con. All groups treated with tested synthetic cannabinoids showed decreased weight gain rate in a ~~dose-dependent manner~~. ~~A total~~ of ~~5 mice in~~ the ~~JWH-081 (5 mg/kg, i.p.) treated group and 6 mice~~ in ~~the Click Link JWH~~-~~210 (5 mg/kg, i~~.~~p.) treated group showed loss~~ of ~~traction, of which 4 and 5 showed tremor, respectively. Memory retention was measured after~~ the ~~memory acquisition was tested as a probe trial.<br>About Powder JWH~~-~~2<br><br><br>High resolution mass spectrometry such as LC~~-~~QTOF-MS allows~~ the ~~detection and identification of a broad spectrum of recreational drugs~~, ~~including new psychoactive substances~~. ~~A point-~~of-~~care drugs of abuse~~ (~~DOA~~) ~~test was initially performed on the urine of the patient. He confirmed drinking 750 ml energy drink without any further consumption of food~~ and ~~using an e-cigarette~~ from ~~Gaziantep~~, ~~Turkey 10 seconds before the onset of his first symptoms. He usually smokes a pack of cigarettes a day and sometimes smokes e~~-~~cigarettes. Combined with non~~-~~specific~~, ~~transient symptoms~~, ~~clinical recognition of SCRA intoxication is challenging~~ .<br>~~Data availability~~ <br>~~The intensity is plotted against the retention time for both chromatograms, demonstrating the Click Link presence and elution profiles of nicotine and ADB~~-~~BUTINACA in the analysed vape liquid sample. LC~~-~~QTOF~~-~~MS Chromatograms of Nicotine (Top) and~~ ADB-~~BUTINACA (Bottom) in the Vape Liquid used by the patient. The LC-QTOF-MS analysis showed that the e-liquid contained nicotine and~~ ADB-~~BUTINACA (Fig. 1~~)~~. Because the point~~-of-~~care DOA test is generally not able to detect synthetic recreational drug substances~~, ~~the liquid of the e~~-~~cigarette was thereafter screened using liquid chromatography~~-~~quadrupole time-of-flight mass spectrometry~~ (LC-~~QTOF~~-MS) ~~on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER, the nausea complaints of the patient~~ were ~~reduced and the patient was discharged hom~~<br><br>4. Drugs <br>In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval. Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor.<br>Michael B Gatch <br>Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the [https://cannabinoidsrc4f-adb.com/ ~~Click Link~~] highest dose tested (0.5 mg/kg).<br>Figure 1. <br>There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016). As previously mentioned, all of the compounds tested in the present study (MDMB-PINACA, MDMB-CHMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA) act as agonists at CB1 receptors (Banister et al., 2015, 2016; Gamage et al., 2018), which suggests these compounds will produce Δ9-THC-like effects, including abuse liability. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the ~~mic~~	+	These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br><br>The current study indicates that the test compounds produce locomotor depression similar to that of Δ9-THC, and fully substitute for the discriminative stimulus effects of Δ9-THC. In summary, these 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA have similar abuse liability as Δ9-tetrahydrocannabinol and should be controlled in a similar fashion. Much of the in vivo cannabinoidsrc4f-adb.com testing of the synthetic cannabinoid compounds have been pre-clinical studies focused on their cannabinoid-like effects or like the present study, focused on their abuse liability. There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016<br><br>5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br>4. Drugs <br>In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval. Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor.<br>Michael B Gatch <br>Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the [https://cannabinoidsrc4f-adb.com/ cannabinoidsrc4f-adb.com] highest dose tested (0.5 mg/kg).<br>Figure 1. <br>There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016). As previously mentioned, all of the compounds tested in the present study (MDMB-PINACA, MDMB-CHMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA) act as agonists at CB1 receptors (Banister et al., 2015, 2016; Gamage et al., 2018), which suggests these compounds will produce Δ9-THC-like effects, including abuse liability. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mice.<br>Michael B Gat<br><br><br>Similarly, precursor ion identified at m/z 380 (B19/B21, B23/B25) was 16 Da higher than the 4F-MDMB-BINACA, indicating monohydroxylation at the butyl side chain (B19/B21) and indazole (B23/B25) moieties with product ions m/z 145 and 161, respectively. Metabolites identified at m/z 366 (B8, B9, B13), which was 16 Da higher than the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), confirmed monohydroxylation upon ester hydrolysis. Death involving these drugs have been reported [5,6,7,8,9], and this raises public health and social concerns. Due to their similar physiological effects to the principal psychoactive component of cannabis, Δ9-tetrahydrocannabinol (THC), SCBs are gaining popularity and are often abused as recreational drugs. The fact that similar 4F-MDMB-BINACA and ethanol concentrations were detected in the postmortem blood samples of both victims suggests that both substances played a role in the fatal outcom

← Older revision		Revision as of 03:30, 27 May 2026
Line 1:		Line 1:
−	All of the compounds tested in the present study depressed locomotor activity as is typical for other synthetic cannabinoids (see review by Wiley et al., 2017). Average horizontal activity counts/10 min as a function of time (10 min bins) and dose. Depressant effects of 1.33 mg/kg were observed within 10 min following administration and peak depressant effects were ~~[https://cannabinoidsrc4f-adb.com/ 4F ADB]~~ observed between 0–30 min. Duration of the locomotor depression increased over dose from 30 min following 0.1 mg/kg to 2.5 h following 1 mg/k<br><br><br>~~Such decrease remained 2 hr after~~ the ~~administration (Table 4). In locomotor activity~~, ~~methamphetamine treated group showed approximately 4~~.~~2 times increase compared~~ to the ~~negative control treated group~~. ~~Change of body weight following the treatments~~ with ~~JWH-081~~ and ~~JWH-210 in mic~~<br><br>~~Figure 1.~~ <br>~~Each training session lasted~~ a ~~maximum of 10 min, and the rats could earn up to 20 food pellets~~. ~~Thirty minutes prior to the training sessions, rats received an injection~~ of ~~either vehicle or Δ9-THC and were subsequently placed~~ in the ~~behavior~~-~~testing chambers, where food~~ (~~45-~~mg ~~food pellets; Bio-Serve~~, ~~Frenchtown, NJ~~) ~~was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling~~ and ~~was illuminated only when~~ the ~~levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty~~-~~four male Sprague-Dawley rats were obtained from Envigo~~ (~~Houston~~, TX)~~. Male ND4 Swiss–Webster mice were obtained from Envigo (Houston~~, ~~TX) at approximately 8 weeks~~ of ~~age~~ and ~~maintained in~~ the ~~University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin~~<br><br><br>LC-QTOF-MS ~~represents a significant advancement in~~ the ~~field of drug~~ detection~~, offering higher sensitivity, specificity,~~ and a ~~broader~~ spectrum of ~~detectable~~ substances. ~~Despite all negative results in the~~ point-of-care ~~test for recreational~~ drugs~~, the liquid chromatography-quadrupole time-~~of~~-flight mass spectrometry~~ (~~LC-QTOF-MS~~) ~~analysis showed that~~ the ~~liquid~~ of the e-cigarette ~~contained ADB-BUTINACA~~, a ~~synthetic cannabinoid. We report~~ a 27-~~year~~-~~old man who was admitted to the emergency room because of sudden 4F ADB headache~~, ~~nausea~~, ~~vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection~~ is ~~not commonly available~~.<br>Data availability <br>~~When clinical presentation~~ and~~/or initial DOA testing results are inconclusive, additional testing with~~ LC-QTOF-MS ~~can be valuable~~ and ~~is recommended~~. ~~SCRAs~~ and ~~other NPS may not be detected by point~~-~~of-care DOA tests~~. ~~In this case,~~ the point-of-care DOA ~~urine screening was~~ not able to detect ~~the~~ synthetic cannabinoid ADB-BUTINAC<br><br><br>JWH-210 Chemical Powder offers a reliable solution for laboratories seeking a compound that meets stringent requirements. Researchers often require compounds that are consistent and dependable, and this product delivers on both fronts. Whether used in small-scale experiments or larger research projects, the ~~compound maintains its integrity under recommended storage conditions. This ensures ease~~ of handling and precise measurement during laboratory use. Each batch undergoes detailed verification to ensure purity, consistency, and accuracy, making it suitable for controlled experimental environments. This study was ~~supported by a grant (13181MFDS654)~~ of ~~the National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Republic of Kore<br><br><br>As synthetic cannabinoid receptor agonists~~ (SCRA) are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests. He confirmed that he had been vaping an electronic cigarette (e-~~cigarette~~) ~~earlier that day just before~~ the ~~onset of his symptoms~~. ~~Metabolic acidosis (1/3, 0/7)~~ and ~~respiratory acidosis (1/3~~, ~~0/7), All 10 patients recovered with supportive care, including intubation and ventilation for one case. In 3 cases ADB-BUTINACA was~~ the ~~only substance detected, while in seven other substances~~ of ~~misuse~~ were ~~also detected including other SCRA, opioids, benzodiazepines cocaine~~ and ~~pregabali~~<br><br>4. Drugs <br>In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval. Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor.<br>Michael B Gatch <br>Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the ~~4F ADB~~ highest dose tested (0.5 mg/kg).<br>Figure 1. <br>There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016). As previously mentioned, all of the compounds tested in the present study (MDMB-PINACA, MDMB-CHMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA) act as agonists at CB1 receptors (Banister et al., 2015, 2016; Gamage et al., 2018), which suggests these compounds will produce Δ9-THC-like effects, including abuse liability. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mic	+	All of the compounds tested in the present study depressed locomotor activity as is typical for other synthetic cannabinoids (see review by Wiley et al., 2017). Average horizontal activity counts/10 min as a function of time (10 min bins) and dose. Depressant effects of 1.33 mg/kg were observed within 10 min following administration and peak depressant effects were Click Link observed between 0–30 min. Duration of the locomotor depression increased over dose from 30 min following 0.1 mg/kg to 2.5 h following 1 mg/k<br><br><br>This makes JWH-210 powder one of the most powerful compounds in its class, often used in incense blends and research settings. Our commitment to quality and customer satisfaction makes us the best place for jwh 210 buy-whether you need it for research, incense blends, or other legal applications. For qualified professionals, investing in high-quality, verified material ensures accuracy, safety, and regulatory compliance. Prioritize vendors providing full analytical validation, transparent documentation, and compliance with international controls. Value is best assessed through consistency, verifiable purity, and regulatory compliance—not cost alon<br><br><br>Observation item 1st injection 2nd injection 3rd injection 4th injection 5th injection Con. All groups treated with tested synthetic cannabinoids showed decreased weight gain rate in a dose-dependent manner. A total of 5 mice in the JWH-081 (5 mg/kg, i.p.) treated group and 6 mice in the Click Link JWH-210 (5 mg/kg, i.p.) treated group showed loss of traction, of which 4 and 5 showed tremor, respectively. Memory retention was measured after the memory acquisition was tested as a probe trial.<br>About Powder JWH-2<br><br><br>High resolution mass spectrometry such as LC-QTOF-MS allows the detection and identification of a broad spectrum of recreational drugs, including new psychoactive substances. A point-of-care drugs of abuse (DOA) test was initially performed on the urine of the patient. He confirmed drinking 750 ml energy drink without any further consumption of food and using an e-cigarette from Gaziantep, Turkey 10 seconds before the onset of his first symptoms. He usually smokes a pack of cigarettes a day and sometimes smokes e-cigarettes. Combined with non-specific, transient symptoms, clinical recognition of SCRA intoxication is challenging .<br>Data availability <br>The intensity is plotted against the retention time for both chromatograms, demonstrating the Click Link presence and elution profiles of nicotine and ADB-BUTINACA in the analysed vape liquid sample. LC-QTOF-MS Chromatograms of Nicotine (Top) and ADB-BUTINACA (Bottom) in the Vape Liquid used by the patient. The LC-QTOF-MS analysis showed that the e-liquid contained nicotine and ADB-BUTINACA (Fig. 1). Because the point-of-care DOA test is generally not able to detect synthetic recreational drug substances, the liquid of the e-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER, the nausea complaints of the patient were reduced and the patient was discharged hom<br><br>4. Drugs <br>In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval. Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor.<br>Michael B Gatch <br>Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the [https://cannabinoidsrc4f-adb.com/ Click Link] highest dose tested (0.5 mg/kg).<br>Figure 1. <br>There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016). As previously mentioned, all of the compounds tested in the present study (MDMB-PINACA, MDMB-CHMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA) act as agonists at CB1 receptors (Banister et al., 2015, 2016; Gamage et al., 2018), which suggests these compounds will produce Δ9-THC-like effects, including abuse liability. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mic

← Older revision		Revision as of 07:07, 26 May 2026
Line 1:		Line 1:
−	~~A 30-min period, beginning when maximal depression~~ of locomotor activity ~~first appeared~~ as a function of dose, ~~was used for analysis~~ of ~~dose~~-~~response data~~ and ~~calculation~~ of ~~ED50 values~~. ~~During test~~ sessions, ~~both levers~~ were ~~active~~, ~~such that~~ ten ~~consecutive~~ responses on ~~either~~ lever ~~led~~ to ~~i thought about this reinforcement. The substitution tests occurred~~ only if the ~~rats had achieved 85~~% ~~injection~~-~~appropriate responding on~~ the two prior ~~training sessions.~~<br>~~The locomotor activity assay was used to identify approximate time courses and dose ranges~~ of ~~psychoactive effects~~, ~~which is useful for identifying parameters for drug discrimination experiments~~ and ~~are also predictive~~ of the time ~~course~~ of the ~~psychoactive effects in human users. The purpose~~ of the ~~present study~~ was to ~~assess~~ the ~~abuse liability~~ of ~~5F-MDMB-PINACA~~, ~~MDMB-CHIMICA~~, ~~MDMB-FUBINACA, ADB-FUBINACA~~, and ~~AMB-FUBINACA~~. ~~Since there~~ is ~~currently no robust measure of the reinforcing~~/~~rewarding effects of cannabinoids~~, ~~drug discrimination~~ is ~~currently the best model for assessing abuse liability of cannabinoids~~. ~~The findings produce an apparent paradox, since CPP~~ and ~~self-administration predict with high reliability the likelihood that a compound will~~ be ~~abused~~ by ~~humans~~, ~~and cannabinoids are well~~-~~known~~ to ~~produce active drug~~-~~seeking in human~~<br><br><br>~~In summary,~~ JWH-210 Chemical Powder ~~stands out as~~ a ~~high-quality research~~ compound ~~designed for professionals who demand accuracy, consistency~~, and ~~reliability~~. ~~This commitment to [https://cannabinoidsrc4f~~-~~adb.com/ i thought about this] quality makes it a trusted option for professionals who require dependable compounds for their work. From sourcing raw materials to final packaging~~, ~~every stage of~~ the ~~process is monitored to ensure compliance with laboratory-grade expectations~~. This ~~makes it an ideal choice for laboratories that prioritize both efficiency~~ and ~~compliance with research standards~~.~~<br>Key Features and Specifications~~ to ~~Evaluate <br>In case of cannabis or Δ9-tetrahydrocannabinol~~, ~~there are many i thought about this previous studies regarding with their dependence potential and neurotoxicity (Cororan~~, ~~et al., 1974; Harris, et al., 1974; Leite~~ and ~~Culini~~, ~~1974; Hutcheson, et al~~.~~, 1998~~)~~. After administering test substances once every other day for 10 days~~, ~~brain samples~~ of ~~mice were collected, especially at nucleus accumbens~~ and ~~hippocampus regions.~~ Drug ~~was administered 5 times every other day~~, ~~and the first trial was performed 2 h after the last administration.~~<br>~~How to Choose Powder JWH-210~~ <br>~~When learning how~~ to ~~choose powder JWH-210, the most critical factor~~ is ~~verifying high chemical purity~~ (~~≥98%~~) ~~from a reputable supplier with independent lab testing. We also demonstrated~~ that ~~JWH-210 administration resulted in~~ the ~~decrease~~ of ~~expression levels of T-cell activator including Cd3e, Cd3g, Cd74p31~~, and ~~Cd74p41, while JWH-030 increased Cd3g levels. JWH-210~~ (~~10 mg~~/~~kg,~~ 3 ~~days~~, ~~i.p.~~) ~~is more likely to have cytotoxicity and reduce lymphoid organ weight than JWH-030 of ICR mice in vivo. Users are expected to handle the compound in accordance~~ with ~~all applicable regulations~~ and ~~safety guidelines within their jurisdiction~~. ~~It is important to note that JWH~~-~~210 Chemical Powder is intended strictly for research and laboratory use~~ only~~. Its reputation for purity~~ and ~~stability has contributed to its widespread use in controlled environments where precision is paramoun~~<br><br>~~AMB-FUBINACA has~~ been ~~implicated in severe~~ adverse effects in ~~recreational users~~ (~~Adams~~ et al., ~~2017; Hamilton~~ et al., ~~2017~~)~~, which suggests that~~ the ~~range between behaviorally active and toxic doses~~ of ~~AMB~~-~~FUBINACA is narro<br><br><br>Moreover~~, a ~~study~~ conducted in the ~~United Kingdom investigated components~~ of ~~e-liquids in 112 samples originating from prisoners~~, ~~teenagers~~ and ~~test purchases~~ of ~~commercially available e~~-~~cigarettes taken between 2014 and 2021~~ . ~~This is the first case report that describes the toxicological symptoms of vaping ADB~~-~~BUTINACA. Results~~ of ~~the DOA test (including testing for amphetamines~~, ~~methamphetamines, barbiturates, benzodiazepines, cocaine, methadone, opioids, cannabis, tricyclic antidepressants) were available within 30 minutes~~ and ~~were all negative. We report~~ a ~~case of an involuntary intoxication of the SCRA ADB-BUTINACA after vaping~~. ~~There are several pitfalls~~ in ~~the detection~~ of ~~SCRA in samples taken from~~ the ~~patien~~<br><br>~~The findings produce an apparent paradox~~, ~~since CPP~~ and ~~self~~-~~administration predict with high reliability~~ the ~~likelihood that a compound will be abused by humans~~, and ~~cannabinoids are well-known~~ to ~~produce active drug-seeking in human~~<br><br>~~<br>A limitation of this case report~~ is that ~~we did not have~~ a ~~urine sample available for additional NPS testing. Point~~-of-~~care DOA tests using urine~~ to ~~screen for misuse~~ of ~~multiple substances~~, ~~regularly include cannabis~~, ~~amphetamines~~, ~~cocaine, opioids~~, ~~benzodiazepines~~ and ~~methadone~~. ~~THC~~, ~~methamphetamine~~, ~~SRCA~~, ~~lysergic acid diethylamide (LSD~~), ~~gamma~~-~~hydroxybutyrate (GHB) and ketamine are likely to become volatile under~~ the ~~temperature of current e-cigarettes~~, ~~while crack cocaine is hard to vaporise~~. ~~A systematic review including data of 114 patients of~~ which the ~~majority was intoxicated due to SCRA smoking revealed~~ that ~~45 % of~~ the ~~patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours~~	+	All of the compounds tested in the present study depressed locomotor activity as is typical for other synthetic cannabinoids (see review by Wiley et al., 2017). Average horizontal activity counts/10 min as a function of time (10 min bins) and dose. Depressant effects of 1.33 mg/kg were observed within 10 min following administration and peak depressant effects were [https://cannabinoidsrc4f-adb.com/ 4F ADB] observed between 0–30 min. Duration of the locomotor depression increased over dose from 30 min following 0.1 mg/kg to 2.5 h following 1 mg/k<br><br><br>Such decrease remained 2 hr after the administration (Table 4). In locomotor activity, methamphetamine treated group showed approximately 4.2 times increase compared to the negative control treated group. Change of body weight following the treatments with JWH-081 and JWH-210 in mic<br><br>Figure 1. <br>Each training session lasted a maximum of 10 min, and the rats could earn up to 20 food pellets. Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling and was illuminated only when the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, TX). Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks of age and maintained in the University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin<br><br><br>LC-QTOF-MS represents a significant advancement in the field of drug detection, offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoid. We report a 27-year-old man who was admitted to the emergency room because of sudden 4F ADB headache, nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly available.<br>Data availability <br>When clinical presentation and/or initial DOA testing results are inconclusive, additional testing with LC-QTOF-MS can be valuable and is recommended. SCRAs and other NPS may not be detected by point-of-care DOA tests. In this case, the point-of-care DOA urine screening was not able to detect the synthetic cannabinoid ADB-BUTINAC<br><br><br>JWH-210 Chemical Powder offers a reliable solution for laboratories seeking a compound that meets stringent requirements. Researchers often require compounds that are consistent and dependable, and this product delivers on both fronts. Whether used in small-scale experiments or larger research projects, the compound maintains its integrity under recommended storage conditions. This ensures ease of handling and precise measurement during laboratory use. Each batch undergoes detailed verification to ensure purity, consistency, and accuracy, making it suitable for controlled experimental environments. This study was supported by a grant (13181MFDS654) of the National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Republic of Kore<br><br><br>As synthetic cannabinoid receptor agonists (SCRA) are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests. He confirmed that he had been vaping an electronic cigarette (e-cigarette) earlier that day just before the onset of his symptoms. Metabolic acidosis (1/3, 0/7) and respiratory acidosis (1/3, 0/7), All 10 patients recovered with supportive care, including intubation and ventilation for one case. In 3 cases ADB-BUTINACA was the only substance detected, while in seven other substances of misuse were also detected including other SCRA, opioids, benzodiazepines cocaine and pregabali<br><br>4. Drugs <br>In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval. Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor.<br>Michael B Gatch <br>Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 0–30 min following administration. Tremors were observed 30 minutes following 1 mg/kg AMB-FUBINACA in 3 of 8 mice (data not shown). Substantial depressant effects were observed within the first 10 min, and maximal depression was observed between 10–40 min and lasted up to 2.5 to 3 h at the 4F ADB highest dose tested (0.5 mg/kg).<br>Figure 1. <br>There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016). As previously mentioned, all of the compounds tested in the present study (MDMB-PINACA, MDMB-CHMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA) act as agonists at CB1 receptors (Banister et al., 2015, 2016; Gamage et al., 2018), which suggests these compounds will produce Δ9-THC-like effects, including abuse liability. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mic